Missense p53 mutations occur frequently in cancer and are concentrated at CG sites30 in the DNA binding domain, owing to frequent deamination of 5-methylcytosine leading to C to T conversion31 and binding of DNA adducts to certain methylated CGs32. This evidence concerns the gene TP53 and cancer.